K.C. Pharmaceuticals of Pomona, California, began a voluntary recall of its eye drops on Sept. 11 by notifying customers by email, and the U.S. Food and Drug Administration classified it as a Class II recall on Oct. 5, according to the agency's enforcement report. The recall covers 4,848,342 cartons of 0.5 fl oz (15 mL) eye drops distributed across the United States. The reason given is "lack of assurance of sterility."
The FDA record does not say any of the products were found to be contaminated, and it does not mention any injuries or infections. The agency uses Class II for products that may cause temporary or medically reversible health problems, where the chance of serious harm is remote. Sterility still matters for eye drops, because they are applied directly to the eye.
Which brands are affected
The recalled products are redness relievers, lubricant and dry eye drops, and artificial tears sold mostly under store labels: Walmart's Equate, Target's up & up, Walgreens, Kroger, H-E-B, Publix, Harris Teeter, Leader, TopCare, GoodSense, Quality Choice, Foster & Thrive, Good Neighbor Pharmacy, Best Choice, Equaline, Discount Drug Mart, Circle K and Lil' Drug Store. Some lots of Clear Eyes Redness Relief, Mike Tyson Red Eye Drops and Exchange Select drops sold at military exchanges are also on the list.

Not every eye drop sold at these stores is part of the recall. Only specific lots are affected, with expiration dates ranging from November 2026 to August 2028.
How to check your bottle
The lot number and expiration date are printed on the carton and the bottle. Lot numbers in this recall begin with LT, AR, RG, SU, CM, AT, AC or RL, followed by 24 or 25, for example RG25K04. A matching prefix alone is not enough: only the exact lot numbers listed in the FDA's Enforcement Report, which can be searched for "K.C. Pharmaceuticals," are affected.
Anyone who has a recalled product should stop using it and contact the store where they bought it. People who notice eye pain, redness, discharge or changes in vision after using eye drops should contact a health care provider.
Second recall this year
This is the second large recall of K.C. Pharmaceuticals eye drops in 2026. In March, the company recalled 3,111,072 bottles for the same reason, and the FDA classified that recall as Class II on March 31.